Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 139 (6) , 962-970
- https://doi.org/10.1067/mhj.2000.106915
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre studyThe Lancet, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996
- The broad spectrum of unstable angina pectoris and its implications for future controlled trialsThe American Journal of Cardiology, 1986